Show simple item record

dc.contributor.authorClark, CE
dc.date.accessioned2019-02-07T13:03:01Z
dc.date.issued2018-07-12
dc.description.abstractHypertension is predominantly detected and managed in primary or community care settings. Nurses are key members of the multidisciplinary primary care team, and are commonly involved in measuring or managing blood pressure. Nurses undertake a range of tasks in hypertension care and many randomised controlled trials of different nurse led interventions have been conducted, providing evidence from different populations. There is good evidence to support better blood pressure outcomes when nurses deliver care face to face, but not remotely. Other important components of these complex interventions appear to be the inclusion of a structured care algorithm, ability to prescribe or altering medications, and maintaining contact at least monthly until blood pressure is controlled to target. There is limited reporting of the costs of interventions and evidence for cost effectiveness of nurse led care compared to usual care is lacking, and there is no clear evidence from longer term follow up of the effect of nurse led interventions on cardiovascular outcomes. The design of programmes for nurse led care in hypertension should take account of the existing evidence and areas of uncertainly. Nurses generally work within teams and future studies of team approaches to hypertension, either including or led by nurses, are needed. Any future studies of nurse led care should include a robust cost effectiveness analysis.en_GB
dc.identifier.citationIn: Drug Adherence in Hypertension and Cardiovascular Protection, ed. Michel Burnier. See full item metadata for this informationen_GB
dc.identifier.urihttp://hdl.handle.net/10871/35796
dc.language.isoenen_GB
dc.publisherSpringeren_GB
dc.relation.urlhttps://www.springer.com/gb/book/9783319765921en_GB
dc.rights.embargoreasonPublisher policy
dc.rights© 2019. Springer International Publishing AG, part of Springer Natureen_GB
dc.titleNurse led interventions in Hypertensionen_GB
dc.typeBook chapteren_GB
dc.date.available2019-02-07T13:03:01Z
dc.contributor.editorBurnier, Men_GB
dc.identifier.isbn3319765930
dc.identifier.isbn9783319765938
dc.relation.isPartOfDrug Adherence in Hypertension and Cardiovascular Protectionen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from Springer via the DOI in this record.en_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2018-07-12
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2018
rioxxterms.typeBook chapteren_GB
refterms.dateFCD2019-02-07T12:57:10Z
refterms.versionFCDAM


Files in this item

This item appears in the following Collection(s)

Show simple item record